PL370423A1 - Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments - Google Patents

Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments

Info

Publication number
PL370423A1
PL370423A1 PL03370423A PL37042303A PL370423A1 PL 370423 A1 PL370423 A1 PL 370423A1 PL 03370423 A PL03370423 A PL 03370423A PL 37042303 A PL37042303 A PL 37042303A PL 370423 A1 PL370423 A1 PL 370423A1
Authority
PL
Poland
Prior art keywords
oxadiazol
medicaments
alkoxy
ones
phenyl
Prior art date
Application number
PL03370423A
Other languages
English (en)
Polish (pl)
Inventor
Karl Schoenafinger
Stefan Petry
Günter Müller
Armin Bauer
Hubert Otto Heuer
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of PL370423A1 publication Critical patent/PL370423A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
PL03370423A 2002-02-28 2003-02-14 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments PL370423A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen

Publications (1)

Publication Number Publication Date
PL370423A1 true PL370423A1 (en) 2005-05-30

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03370423A PL370423A1 (en) 2002-02-28 2003-02-14 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments

Country Status (22)

Country Link
EP (1) EP1480960B1 (enExample)
JP (1) JP4486363B2 (enExample)
KR (1) KR20040095240A (enExample)
CN (1) CN1639137A (enExample)
AR (1) AR038701A1 (enExample)
AT (1) ATE557012T1 (enExample)
AU (1) AU2003226977A1 (enExample)
BR (1) BR0307921A (enExample)
CA (1) CA2477031A1 (enExample)
CO (1) CO5611146A2 (enExample)
DE (1) DE10208987A1 (enExample)
HR (1) HRP20040782A2 (enExample)
HU (1) HUP0402671A3 (enExample)
IL (1) IL163683A0 (enExample)
MA (1) MA27172A1 (enExample)
MX (1) MXPA04007960A (enExample)
NO (1) NO20044090L (enExample)
PE (1) PE20030928A1 (enExample)
PL (1) PL370423A1 (enExample)
RU (1) RU2004128933A (enExample)
TW (1) TW200400951A (enExample)
WO (1) WO2003072555A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
CA2585175A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
CA2710743A1 (en) * 2007-12-27 2009-07-09 Bial-Portela & Ca., S.A. 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
WO2001066531A1 (de) * 2000-03-07 2001-09-13 Aventis Pharma Deutschland Gmbh Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one (und) ihre verwendung zur hemmung der hormonsensitiven lipase

Also Published As

Publication number Publication date
HRP20040782A2 (en) 2005-02-28
NO20044090L (no) 2004-11-04
PE20030928A1 (es) 2003-12-17
EP1480960B1 (de) 2012-05-09
EP1480960A1 (de) 2004-12-01
AU2003226977A1 (en) 2003-09-09
AR038701A1 (es) 2005-01-26
JP4486363B2 (ja) 2010-06-23
CO5611146A2 (es) 2006-02-28
KR20040095240A (ko) 2004-11-12
MA27172A1 (fr) 2005-01-03
CN1639137A (zh) 2005-07-13
RU2004128933A (ru) 2005-04-20
BR0307921A (pt) 2004-12-21
MXPA04007960A (es) 2004-11-26
ATE557012T1 (de) 2012-05-15
TW200400951A (en) 2004-01-16
IL163683A0 (en) 2005-12-18
HUP0402671A2 (hu) 2005-04-28
WO2003072555A1 (de) 2003-09-04
CA2477031A1 (en) 2003-09-04
DE10208987A1 (de) 2003-09-11
JP2005519085A (ja) 2005-06-30
HUP0402671A3 (en) 2006-07-28

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IL219671A0 (en) 1,2- benzoxazoles and use thereof in the preparation of a medicament
AU2003292239A8 (en) Novel carboxamides, the production and use thereof as medicaments
IL143349A0 (en) Azepinoindole derivatives, the production and use thereof
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
IL142917A0 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
EP1617807A4 (en) SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
IL138702A0 (en) Substituted indolinones, the production thereof and their use as medicaments
HRPK20010007B1 (en) Benzimidazoles, production thereof and use thereof as medicaments
IL142096A0 (en) Indeno-, naphtho-and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL162669A0 (en) Antichlinergic agents, method for producing the same and use thereof as medicaments
HUP0203290A3 (en) Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
DE60334632D1 (de) Mechanolumineszenzstoff und dessen herstellung
PL374879A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
TWI348382B (en) N-acetylglucosamine derivatives, and the use thereof
AU2003254556A1 (en) Indoline derivatives substituted in position 6, production and use thereof as medicaments
HUP0402671A3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
HRP20040691A2 (en) 2'-halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
IL147414A0 (en) Ifnar2 mutants, their production and use
MXPA03006580A (es) Amidas de acido carboxilico, su produccion y su uso como medicamentos.
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof
AU2002331114A1 (en) Tetrahydroisochinolines, their production and the use thereof as analgesics

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)